We need to reauthorize the Creating Hope Act.

We all need to love the FDA, and not do fire-alarm, knee-jerk oversight.

We want you to use the tools that we have already given you. This is legislation that already exists.

We are asking for a very specific carve-out for a very small exception that does not necessarily--well, it does not cost us any money.

We need to move toward personalized medicine, in these cases.

What do you think that those of us who are sitting over here on this side of the dais can do, either through legislation or, maybe, through partnering with the Administration, to improve patient access to new treatments or to new therapies?

Treatment should not be up to somebody who has no involvement in my medical treatment.

It will also force companies to have one point of contact at the company for somebody like Matthew to call.

That is over half of all of the drugs?

And, that is us?

We are 25 years behind.

OK. Thank you.

Do you have any examples of that you might be able to share with us, either on the record or here, today?

You should not have to beg the Federal Government for permission to save your life.

one concern that I think that we are hearing here, today, is about a lack of access to information about which programs are available to help people who are facing these life-threatening conditions.

And taking a step back, what is the reason for not continuing with the Federal Investigative Services? Why do we need this new bureau?

The hearings last year in Oversight Committee exposed fundamental weaknesses in our nation's IT infrastructure.

And if they want more money to do the IT system upgrades and so on, where would that money come from?